Trevena Stock Price - TRVN

0.02 (3.92%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Trevena Inc TRVN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0001 0.02% 0.51 0.50 0.53 0.5033 0.5099 00:00:03
Bid Price Ask Price Spread Spread % News
0.51 0.65 0.14 21.54% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,113 1,180,965 $ 0.5153615 $ 608,624 870,016 0.458 - 1.65
Last Trade Time Type Quantity Stock Price Currency
19:29:23 formt 1,000 $ 0.53 USD

Trevena Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 49.84M 97.73M $ -30.78M -0.27 - 95.16M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 2.00 2.60%

more financials information »

Trevena News

Loading Messages....

Latest TRVN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TRVN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.53170.570.4580.49098191,376,501-0.0217-4.08%
1 Month0.660.6930.4580.5494499954,299-0.15-22.73%
3 Months0.900.990.4580.6909686801,570-0.39-43.33%
6 Months0.951.050.4580.7383825667,669-0.44-46.32%
1 Year1.561.650.4580.9522054693,679-1.05-67.31%
3 Years3.333.640.38231.441,338,759-2.82-84.68%
5 Years6.7913.570.38232.901,050,989-6.28-92.49%

Trevena Description

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.